TFDA-2024-0091-V091
Minor variation for application TFDA-2024-0091. Minor variation: Facility Change for Kcluximab — critical change
Variation Number
TFDA-2024-0091-V091
Type
Minor
Application
Change
Status
Submitted
Fee
€3,986
Submitted
—
Approved
—
Description
Minor variation: Facility Change for Kcluximab — critical change